Phibro Animal Health reported $3.03M in Interest Expense on Debt for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Expense On Debt Change
Ani Pharmaceuticals ANIP:US $ 2.53M 77K
Aphria Inc APH:CN C$ 10.45M 3.97M
Aurora Cannabis Inc ACB:CN 15.88M 1.11M
Bristol Myers Squibb BMY:US $ 330M 23M
Canopy Growth Corp WEED:CN C$ 24.56M 19.81M
Eli Lilly And LLY:US $ 86.9M 0.9M
Endo International Ordinary Shares ENDP:US $ 141.64M 6.95M
Gw Pharmaceuticals GWPH:US $ 0.29M 0.02M
Henry Schein HSIC:US $ 6.38M 0.11M
Idexx Laboratories IDXX:US $ 7.61M 0.03M
JAZZ PHA JAZZ:US $ 69.82M 41.24M
Knight Therapeutics Inc GUD:CN C$ 668K 8K
Lannett LCI:US $ 13.22M 0.59M
Nektar Therapeutics NKTR:US $ 13.09M 0.21M
Pacira Pharmaceuticals PCRX:US $ 7.02M 0.05M
Patterson Companies PDCO:US $ 5.2M 0.48M
Phibro Animal Health PAHC:US $ 3.03M 0.05M
Prestige Brands PBH:US $ 15.08M 3.91M
Supernus Pharmaceuticals SUPN:US $ 5.47M 0.4M
Teva Pharmaceutical Industries TEVA:US $ 240M 1M
Zoetis ZTS:US $ 57M 0M